TCM
TCG Crossover Management Portfolio holdings
AUM
$876M
This Quarter Return
-8.23%
1 Year Return
+23.66%
3 Year Return
+996.72%
5 Year Return
–
10 Year Return
–
AUM
$235M
AUM Growth
+$235M
(-5.5%)
Cap. Flow
+$24.3M
Cap. Flow
% of AUM
10.34%
Top 10 Holdings %
Top 10 Hldgs %
80.18%
Holding
22
New
2
Increased
4
Reduced
4
Closed
–
Top Buys
| 1 |
Kura Oncology
KURA
|
$12.1M |
| 2 |
MoonLake Immunotherapeutics
MLTX
|
$5.25M |
| 3 |
Cogent Biosciences
COGT
|
$4.51M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$3.82M |
| 5 |
89bio
ETNB
|
$3.65M |
Top Sells
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cogent Biosciences
COGT
$1.69B
| $31.4M | 13.34% | 3,481,042 +500,000 | +17% | +$4.51M |
|
|
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $28M | 11.91% | 2,914,250 +397,330 | +16% | +$3.82M |
|
3
Geron
GERN
$893M
| $23.4M | 9.94% | 15,096,342 +810,627 | +6% | +$1.26M |
|
|
4
Kura Oncology
KURA
$686M
| $21.4M | 9.09% | 1,167,642 +661,219 | +131% | +$12.1M |
|
|
CBAY
5
DELISTED
Cymabay Therapeutics
CBAY
| $17.4M | 7.4% | 5,905,400 | – | – |
|
6
Aclaris Therapeutics
ACRS
$209M
| $16M | 6.79% | 1,144,939 | – | – |
|
7
Viridian Therapeutics
VRDN
$1.5B
| $15.2M | 6.46% | 1,314,000 | – | – |
|
|
KDNY
8
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $13.9M | 5.92% | 796,460 -85,893 | -10% | -$1.5M |
|
|
JBIO
9
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $13.9M | 5.91% | 889,572 | – | – |
|
10
Entrada Therapeutics
TRDA
$208M
| $8.08M | 3.43% | 663,694 | – | – |
|
11
Merus
MRUS
$4.98B
| $6.79M | 2.89% | 300,000 | – | – |
|
12
Tyra Biosciences
TYRA
$675M
| $6.41M | 2.72% | 896,418 | – | – |
|
|
AKUS
13
DELISTED
Akouos, Inc. Common Stock
AKUS
| $6.33M | 2.69% | 1,350,006 | – | – |
|
14
Tango Therapeutics
TNGX
$747M
| $5.31M | 2.26% | 1,172,250 -82,250 | -7% | -$373K |
|
|
15
MoonLake Immunotherapeutics
MLTX
$3.54B
| $5.25M | 2.23% | +1,000,000 | New | +$5.25M |
|
|
ALPN
16
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $4.92M | 2.09% | 578,260 -455,962 | -44% | -$3.88M |
|
|
17
89bio
ETNB
$1.34B
| $3.65M | 1.55% | +1,133,196 | New | +$3.65M |
|
18
Zai Lab
ZLAB
$3.68B
| $3.3M | 1.4% | 95,000 | – | – |
|
19
Dianthus Therapeutics
DNTH
$759M
| $2.55M | 1.08% | 2,124,122 | – | – |
|
20
AnaptysBio
ANAB
$569M
| $1.19M | 0.5% | 58,515 | – | – |
|
|
ELEV
21
DELISTED
Elevation Oncology
ELEV
| $777K | 0.33% | 555,000 | – | – |
|
|
PRDS
22
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $181K | 0.08% | 59,039 -170,061 | -74% | -$521K |
|